Stock Comparison

ARGX vs REGN

argenx NV ADR and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$55.44B

$66.35B

P/E (TTM)

39.4

15.5

Forward P/E

34.0

14.1

Price/Sales

11.7

4.5

Price/Book

7.5

2.1

EV/EBITDA

33.9

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

31.40%

29.60%

Operating Margin

30.00%

20.70%

Return on Equity

20.20%

14.50%

Return on Assets

8.86%

6.13%

Growth (YoY)

Revenue Growth

62.60%

19.00%

Earnings Growth

114.00%

-7.20%

Price & Risk

Beta

-0.0

0.2

52-Week High

$934.62

$818.90

52-Week Low

$510.06

$516.07

Analyst Target

$1,041.14

$833.31

Compare ARGX and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.